Idylla NRAS-BRAF Mutation Test receives CE-marking
Idylla™ offers complete CE-marked RAS testing for metastatic CRC.
The existing Idylla™ KRAS Mutation Test in combination with the new Idylla™ NRAS-BRAF Mutation Test enables the detection 39 mutations in the NRAS and KRAS genes and 5 mutations in the BRAF gene according to CAP/AMP/ASCO, NCCN and ESMO guidelines
- Directly on FFPE
- Detecting 23 relevant mutations
- equal to or less than 5% sensitivity*
- Sample-to-result within 2 hours
- less than two minutes hands-on time
Available in New Zealand only.